A guest lecture on “Targeting Epithelial to Mesenchymal Transition by Small Molecule Inhibitor Fisetin in Lung Cancer” was organized on 20^th August 2022. The session was delivered by Dr. Saba Tabasum, Post-Doctoral Research Fellow at Dana Farber Cancer Institute, Harvard Medical School, Boston, USA. The lecture highlighted the therapeutic potential of fisetin as a small molecule inhibitor in regulating epithelial to mesenchymal transition (EMT), a key process in cancer progression and metastasis. The participants gained valuable knowledge about innovative strategies in lung cancer research and treatment.The event was organized by Dr. Sumathi Jones, Head of the Department of Pharmacology.